Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,226,771 papers from all fields of science
Search
Sign In
Create Free Account
DX 8951f
Known as:
DX-8951f
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
exatecan
exatecan mesylate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane…
C. Verschraegen
,
A. Kudelka
,
+6 authors
R. D. de Jager
Cancer Chemotherapy and Pharmacology
2007
Corpus ID: 42904332
Background: DX-8951f is a water-soluble camptothecin derivative with greater in vivo and in vitro activity than topotecan or…
Expand
2004
2004
A phase II study of intravenous DX-8951f administered daily for five days every three weeks to patients with previously untreated metastatic gastric cancer
C. Becerra
,
C. Takimoto
,
+4 authors
R. De Jagger
2004
Corpus ID: 199023626
4126 Background: Exatecan Mesylate (DX-8951f, Daiichi Pharmaceutical Co., Ltd., Japan) was synthesized to impart greater…
Expand